Adjuvant Chemotherapy for HR-Positive Negative Breast Cancer—Clinical Practice Changes Based on TAILORx and RxPONDER Results

Corresponding Author: Victoria S. Blinder, MD, MSc, Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 633 Third Avenue, 4th Floor, New York, NY 10017 (blinderv@mskcc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.